Maryam Ahmadi-Khorram
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maryam Ahmadi-Khorram has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alireza Hatami
Department of Clinical Nutrition, School of Nutrition and Food Science, Food Security Research Center Isfahan University of Medical Sciences Isfahan Iran
4 shared publications - Mohsen Nematy
Department of Nutrition, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran
4 shared publications - Ali Jafarzadeh Esfehani
Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
3 shared publications - Afsane Fadaee
Immunology Research Center Mashhad University of Medical Sciences Mashhad Iran mums.ac.ir
1 shared publication Ahmed Hussein Hasan Alshihmani
Immunology Research Center Mashhad University of Medical Sciences Mashhad Iran mums.ac.ir
1 shared publicationAli Jafarzadeh Esfehani
Metabolic Syndrome Research Center Mashhad University of Medical Sciences Mashhad Iran
1 shared publication
Latest Publications
- Open Access
- 30 August 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (9) , e73139
Mediterranean Diet and Micronutrient Adequacy in Relation to Relapsing‐Remitting Multiple Sclerosis Risk: A Case‐Control Study
Background: Multiple sclerosis (MS) is a chronic autoimmune and neurodegenerative disease influenced by environmental factors, including diet. The Mediterranean Diet (MeDi), rich in anti‐inflammatory and antioxidant compounds, and micronutrient adequacy may reduce MS risk and progression. Aim: This study aims to examine the associations between the Mediterranean Diet Score (MDS), Mean Adequacy Ratio (MAR), and MS risk in a case‐control setting. Methods: This case‐control study included 197 newly diagnosed relapsing‐remitting MS patients (aged 18–65 years) from Iran, and 200 matched controls without neurological diseases. Dietary intake was assessed using a validated semi‐quantitative food frequency questionnaire. MDS was calculated based on nine dietary components, and MAR was computed as the average Nutrient Adequacy Ratio for seven micronutrients. Adjusted binary logistic regression estimated odds ratios (ORs) for MS risk across MDS and MAR tertiles. Results: Higher MDS and MAR were associated with significantly reduced MS risk. Individuals in the highest MDS tertile had 47% lower odds of MS (OR: 0.53, 95% CI: 0.29–0.98, p = 0.04), and those in the highest MAR tertile had 75% lower odds (OR: 0.25, 95% CI: 0.10–0.62, p = 0.002) compared to the lowest tertiles after adjustments. No significant differences in total energy or macronutrient intake were observed between groups. Conclusion: Higher adherence to the Mediterranean Diet and better micronutrient adequacy are associated with a reduced risk of MS. These findings highlight the potential of dietary interventions as a cost‐effective strategy for MS prevention, warranting further longitudinal and interventional studies to establish causality and inform public health strategies. Trial Registration: The Mashhad University of Medical Sciences approved the study with numbers IR.MUMS.REC.1393.182.
- 30 August 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (9) , e73139
Open AccessMediterranean Diet and Micronutrient Adequacy in Relation to Relapsing‐Remitting Multiple Sclerosis Risk: A Case‐Control Study
Background: Multiple sclerosis (MS) is a chronic autoimmune and neurodegenerative disease influenced by environmental factors, including diet. The Mediterranean Diet (MeDi), rich in anti‐inflammatory and antioxidant compounds, and micronutrient adequacy may reduce MS risk and progression. Aim: This study aims to examine the associations between the Mediterranean Diet Score (MDS), Mean Adequacy Ratio (MAR), and MS risk in a case‐control setting. Methods: This case‐control study included 197 newly diagnosed relapsing‐remitting MS patients (aged 18–65 years) from Iran, and 200 matched controls without neurological diseases. Dietary intake was assessed using a validated semi‐quantitative food frequency questionnaire. MDS was calculated based on nine dietary components, and MAR was computed as the average Nutrient Adequacy Ratio for seven micronutrients. Adjusted binary logistic regression estimated odds ratios (ORs) for MS risk across MDS and MAR tertiles. Results: Higher MDS and MAR were associated with significantly reduced MS risk. Individuals in the highest MDS tertile had 47% lower odds of MS (OR: 0.53, 95% CI: 0.29–0.98, p = 0.04), and those in the highest MAR tertile had 75% lower odds (OR: 0.25, 95% CI: 0.10–0.62, p = 0.002) compared to the lowest tertiles after adjustments. No significant differences in total energy or macronutrient intake were observed between groups. Conclusion: Higher adherence to the Mediterranean Diet and better micronutrient adequacy are associated with a reduced risk of MS. These findings highlight the potential of dietary interventions as a cost‐effective strategy for MS prevention, warranting further longitudinal and interventional studies to establish causality and inform public health strategies. Trial Registration: The Mashhad University of Medical Sciences approved the study with numbers IR.MUMS.REC.1393.182.
- Open Access
- 27 May 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (6) , e71915
A Novel Combination of Probiotic Supplements Reduces Gut Permeability, Oxidative Stress, and Inflammation in Undernourished Adults: A Randomized Controlled Trial
Undernutrition is associated with intestinal barrier dysfunction, oxidative stress, and systemic inflammation. This randomized controlled trial investigated the effects of an 8‐week multi‐strain probiotic supplementation combined with an energy‐surplus diet in underweight adults. In this double‐blind, placebo‐controlled trial (IRCT20230310057667N1), 100 underweight adults (BMI < 18.5 kg/m 2 , aged 18–60 years) were randomized (1:1) using sex‐stratified block randomization (block size 4) to receive either two daily probiotic capsules ( Lactobacillus acidophilus LA5 10 9 CFU, Lactobacillus rhamnosus GG 10 9 CFU, Lactobacillus casei 10 9 CFU) plus a 500 kcal/day energy‐surplus diet, or identical placebo plus the same diet. Primary outcome was change in serum zonulin concentration. Secondary outcomes included markers of oxidative stress and inflammation. Per‐protocol analysis was conducted on 95 participants who completed the study. Serum zonulin concentration decreased by a mean of 0.98 ± 1.61 ng/mL in the probiotic group versus 0.22 ± 1.12 ng/mL in the placebo group ( p = 0.047). Median changes in secondary outcomes (probiotic versus placebo) were as follows: total antioxidant capacity +0.40 versus −0.01 mmol/L, total oxidant status −4.22 versus +0.79 μmol/L, glutathione peroxidase +4.0 versus −0.8 nmol/mL, malondialdehyde −0.046 versus +0.006 nmol/mL, C‐reactive protein −0.50 versus +0.10 mg/L, and 1‐h erythrocyte sedimentation rate −1 versus +1 mm/h. The between‐group differences were statistically significant for all outcomes ( p < 0.001 for secondary outcomes; p = 0.047 for serum zonulin). Multi‐strain probiotic supplementation combined with a weight‐gain diet significantly improves gut barrier integrity, reduces oxidative stress and attenuates systemic inflammation in undernourished adults, offering a promising adjunctive nutritional intervention.
- 27 May 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (6) , e71915
Open AccessA Novel Combination of Probiotic Supplements Reduces Gut Permeability, Oxidative Stress, and Inflammation in Undernourished Adults: A Randomized Controlled Trial
Undernutrition is associated with intestinal barrier dysfunction, oxidative stress, and systemic inflammation. This randomized controlled trial investigated the effects of an 8‐week multi‐strain probiotic supplementation combined with an energy‐surplus diet in underweight adults. In this double‐blind, placebo‐controlled trial (IRCT20230310057667N1), 100 underweight adults (BMI < 18.5 kg/m 2 , aged 18–60 years) were randomized (1:1) using sex‐stratified block randomization (block size 4) to receive either two daily probiotic capsules ( Lactobacillus acidophilus LA5 10 9 CFU, Lactobacillus rhamnosus GG 10 9 CFU, Lactobacillus casei 10 9 CFU) plus a 500 kcal/day energy‐surplus diet, or identical placebo plus the same diet. Primary outcome was change in serum zonulin concentration. Secondary outcomes included markers of oxidative stress and inflammation. Per‐protocol analysis was conducted on 95 participants who completed the study. Serum zonulin concentration decreased by a mean of 0.98 ± 1.61 ng/mL in the probiotic group versus 0.22 ± 1.12 ng/mL in the placebo group ( p = 0.047). Median changes in secondary outcomes (probiotic versus placebo) were as follows: total antioxidant capacity +0.40 versus −0.01 mmol/L, total oxidant status −4.22 versus +0.79 μmol/L, glutathione peroxidase +4.0 versus −0.8 nmol/mL, malondialdehyde −0.046 versus +0.006 nmol/mL, C‐reactive protein −0.50 versus +0.10 mg/L, and 1‐h erythrocyte sedimentation rate −1 versus +1 mm/h. The between‐group differences were statistically significant for all outcomes ( p < 0.001 for secondary outcomes; p = 0.047 for serum zonulin). Multi‐strain probiotic supplementation combined with a weight‐gain diet significantly improves gut barrier integrity, reduces oxidative stress and attenuates systemic inflammation in undernourished adults, offering a promising adjunctive nutritional intervention.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Nutrition and Metabolism
- Vol. 2026 (1) , 7365660
Immunomodulatory Probiotics in Psoriasis: Effects on the Gut–Skin–Immune Crosstalk and Systemic Inflammation
Psoriasis is a chronic inflammatory skin disorder characterized by dysregulated immune responses and excessive keratinocyte proliferation, with substantial effects on patients’ quality of life. Evidence suggests that the gut microbiota and the gut–skin–immune axis may contribute to systemic inflammation and immune dysregulation associated with psoriasis. This narrative review examines the potential immunomodulatory role of probiotics in psoriasis, with particular emphasis on strain‐specific biological effects and the mechanisms linking intestinal microbial modulation to psoriasis‐related inflammation. Probiotics may influence intestinal microbial composition, epithelial barrier integrity, microbial metabolite production, and immune signaling. Clinical studies have reported potential improvements in psoriasis severity, inflammatory biomarkers, or quality of life following probiotic supplementation; however, the available evidence remains limited and heterogeneous, with substantial variation in probiotic strains, formulations, doses, treatment durations, concomitant therapies, and clinical outcomes. Unlike previous systematic reviews and meta‐analyses that primarily summarize clinical outcomes, this review integrates clinical findings with strain‐specific mechanistic and experimental evidence to provide a biologically contextualized interpretation of the potential role of probiotics in psoriasis.
- 1 January 2026
- Published by Wiley in Journal of Nutrition and Metabolism
- Vol. 2026 (1) , 7365660
Open AccessImmunomodulatory Probiotics in Psoriasis: Effects on the Gut–Skin–Immune Crosstalk and Systemic Inflammation
Psoriasis is a chronic inflammatory skin disorder characterized by dysregulated immune responses and excessive keratinocyte proliferation, with substantial effects on patients’ quality of life. Evidence suggests that the gut microbiota and the gut–skin–immune axis may contribute to systemic inflammation and immune dysregulation associated with psoriasis. This narrative review examines the potential immunomodulatory role of probiotics in psoriasis, with particular emphasis on strain‐specific biological effects and the mechanisms linking intestinal microbial modulation to psoriasis‐related inflammation. Probiotics may influence intestinal microbial composition, epithelial barrier integrity, microbial metabolite production, and immune signaling. Clinical studies have reported potential improvements in psoriasis severity, inflammatory biomarkers, or quality of life following probiotic supplementation; however, the available evidence remains limited and heterogeneous, with substantial variation in probiotic strains, formulations, doses, treatment durations, concomitant therapies, and clinical outcomes. Unlike previous systematic reviews and meta‐analyses that primarily summarize clinical outcomes, this review integrates clinical findings with strain‐specific mechanistic and experimental evidence to provide a biologically contextualized interpretation of the potential role of probiotics in psoriasis.
- Open Access
- 22 July 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-14
The effect of time-restricted eating on arterial stiffness indices in men with metabolic syndrome: study protocol for a randomized controlled trial
Background: Time-restricted eating (TRE) has been shown to be associated with improvements in some aspects of the metabolic syndrome. Nevertheless, only a few studies have addressed the effect of TRE on pulse wave velocity (PWV). We thus propose a randomized controlled trial to compare the effects of TRE with standard dietary advice on PWV and thereby present the protocol. Methods: Forty-eight participants will be assigned to either TRE or control groups using simple randomization. The TRE group will consume their meals during a 10-h period and experience 14 h of fasting. They will also be advised to consume their last meal no later than 20:00. Both groups will receive standard dietary advice. The participants will be followed for 6 weeks. The primary outcome will be changes in PWV. Laboratory measurements, including lipid profile, liver enzyme tests, fasting blood glucose (FBG), insulin concentrations, and insulin resistance, as well as anthropometric data, blood pressure, basal metabolic rate, appetite status, physical activity level, sleep quality, cognitive function, quality of life, and calorie intake, will be evaluated throughout the study. Discussion: The outcomes of this study will allow a comparison of the effects of TRE and standard dietary recommendations on PWV and other cardiometabolic factors in individuals with metabolic syndrome (MetS). Trial registration: Iranian Registry of Clinical Trials; code: IRCT20201230049889N1; registered on August 14, 2022. The registration of the trial is accessible at: https://www.IRCT.ir/trial/64485?revision=281341.
- 22 July 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-14
Open AccessThe effect of time-restricted eating on arterial stiffness indices in men with metabolic syndrome: study protocol for a randomized controlled trial
Background: Time-restricted eating (TRE) has been shown to be associated with improvements in some aspects of the metabolic syndrome. Nevertheless, only a few studies have addressed the effect of TRE on pulse wave velocity (PWV). We thus propose a randomized controlled trial to compare the effects of TRE with standard dietary advice on PWV and thereby present the protocol. Methods: Forty-eight participants will be assigned to either TRE or control groups using simple randomization. The TRE group will consume their meals during a 10-h period and experience 14 h of fasting. They will also be advised to consume their last meal no later than 20:00. Both groups will receive standard dietary advice. The participants will be followed for 6 weeks. The primary outcome will be changes in PWV. Laboratory measurements, including lipid profile, liver enzyme tests, fasting blood glucose (FBG), insulin concentrations, and insulin resistance, as well as anthropometric data, blood pressure, basal metabolic rate, appetite status, physical activity level, sleep quality, cognitive function, quality of life, and calorie intake, will be evaluated throughout the study. Discussion: The outcomes of this study will allow a comparison of the effects of TRE and standard dietary recommendations on PWV and other cardiometabolic factors in individuals with metabolic syndrome (MetS). Trial registration: Iranian Registry of Clinical Trials; code: IRCT20201230049889N1; registered on August 14, 2022. The registration of the trial is accessible at: https://www.IRCT.ir/trial/64485?revision=281341.
- Open Access
- 1 January 2024
- Published by Korean Society of Clinical Nutrition in Clinical Nutrition Research
- Vol. 13 (1) , 61-73
Association Between the Risk of Multiple Sclerosis and Dietary Proinflammatory/Anti-Inflammatory Food Intake and Dietary Diversity: A Case-Control Study
A diet rich in proinflammatory components and inflammation are suggested to be significant risk factors for multiple sclerosis (MS). This study aimed to investigate the association between the risk of MS and the inflammatory potential of an individual’s diet and dietary diversity through pro-inflammatory/anti-inflammatory food intake score (PAIFIS) and dietary diversity score (DDS). In a hospital-based case–control study, 397 participants, including 197 patients with MS and 200 healthy participants aged over 18 years, were evaluated. The history of smoking, dietary intake, and anthropometric characteristics, including body mass index, waist circumference, total body fat, and fat-free mass were assessed. A validated 160-item semiquantitative food frequency questionnaire was used to calculate the PAIFIS and DDS scores. The mean age of the participants was 32.45 ± 8.66 years, and most were females (274, 79.4%). The PAIFIS score was significantly higher among MS patients than healthy participants (p = 0.001). Between PAIFIS and DDS, only PAFIS was significantly related to MS risk (odds ratio, 1.002; 95% confidence interval, 1.001–1.004; p = 0.001). PAIFIS, as an index of dietary inflammation, can predict MS. Further studies are needed to document these findings.
- 1 January 2024
- Published by Korean Society of Clinical Nutrition in Clinical Nutrition Research
- Vol. 13 (1) , 61-73
Open AccessAssociation Between the Risk of Multiple Sclerosis and Dietary Proinflammatory/Anti-Inflammatory Food Intake and Dietary Diversity: A Case-Control Study
A diet rich in proinflammatory components and inflammation are suggested to be significant risk factors for multiple sclerosis (MS). This study aimed to investigate the association between the risk of MS and the inflammatory potential of an individual’s diet and dietary diversity through pro-inflammatory/anti-inflammatory food intake score (PAIFIS) and dietary diversity score (DDS). In a hospital-based case–control study, 397 participants, including 197 patients with MS and 200 healthy participants aged over 18 years, were evaluated. The history of smoking, dietary intake, and anthropometric characteristics, including body mass index, waist circumference, total body fat, and fat-free mass were assessed. A validated 160-item semiquantitative food frequency questionnaire was used to calculate the PAIFIS and DDS scores. The mean age of the participants was 32.45 ± 8.66 years, and most were females (274, 79.4%). The PAIFIS score was significantly higher among MS patients than healthy participants (p = 0.001). Between PAIFIS and DDS, only PAFIS was significantly related to MS risk (odds ratio, 1.002; 95% confidence interval, 1.001–1.004; p = 0.001). PAIFIS, as an index of dietary inflammation, can predict MS. Further studies are needed to document these findings.